AXL and melanoma: In contrast to the original analyses of these data which compared MITF high proliferative melanoma cells against AXL high invasive cells, the 1252 melanoma scRNA-seq profiles from 19 patients generated by Tirosh et al. (2016) was analysed in an unsupervised manner, without prior assumption of the apparent heterogeneity.